223 related articles for article (PubMed ID: 37239316)
1. Prognostic Values of Gene Copy Number Alterations in Prostate Cancer.
Alfahed A; Ebili HO; Almoammar NE; Alasiri G; AlKhamees OA; Aldali JA; Al Othaim A; Hakami ZH; Abdulwahed AM; Waggiallah HA
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239316
[TBL] [Abstract][Full Text] [Related]
2. Genetic markers associated with early cancer-specific mortality following prostatectomy.
Liu W; Xie CC; Thomas CY; Kim ST; Lindberg J; Egevad L; Wang Z; Zhang Z; Sun J; Sun J; Koty PP; Kader AK; Cramer SD; Bova GS; Zheng SL; Grönberg H; Isaacs WB; Xu J
Cancer; 2013 Jul; 119(13):2405-12. PubMed ID: 23609948
[TBL] [Abstract][Full Text] [Related]
3. Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer.
Jung SH; Shin S; Kim MS; Baek IP; Lee JY; Lee SH; Kim TM; Lee SH; Chung YJ
Eur Urol; 2016 May; 69(5):823-30. PubMed ID: 26542946
[TBL] [Abstract][Full Text] [Related]
4. C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance.
Meng J; Wang LH; Zou CL; Dai SM; Zhang J; Lu Y
Med Sci Monit; 2017 Oct; 23():5176-5183. PubMed ID: 29084195
[TBL] [Abstract][Full Text] [Related]
5. Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
Ebrahimizadeh W; Guérard KP; Rouzbeh S; Bramhecha YM; Scarlata E; Brimo F; Patel PG; Jamaspishvili T; Aprikian AG; Berman D; Bartlett JMS; Chevalier S; Lapointe J
J Mol Diagn; 2020 Oct; 22(10):1246-1263. PubMed ID: 32763409
[TBL] [Abstract][Full Text] [Related]
6. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J
Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
García-Flores M; Casanova-Salas I; Rubio-Briones J; Calatrava A; Domínguez-Escrig J; Rubio L; Ramírez-Backhaus M; Fernández-Serra A; García-Casado Z; López-Guerrero JA
Eur J Cancer; 2014 Nov; 50(17):2994-3002. PubMed ID: 25204806
[TBL] [Abstract][Full Text] [Related]
9. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Grönberg H; Neal DE;
EBioMedicine; 2015 Sep; 2(9):1133-44. PubMed ID: 26501111
[TBL] [Abstract][Full Text] [Related]
10. CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications.
Franch-Expósito S; Bassaganyas L; Vila-Casadesús M; Hernández-Illán E; Esteban-Fabró R; Díaz-Gay M; Lozano JJ; Castells A; Llovet JM; Castellví-Bel S; Camps J
Elife; 2020 Jan; 9():. PubMed ID: 31939734
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the SPOP mutant genomic subclass in prostate cancer.
Shoag J; Liu D; Ma X; Oromendia C; Christos P; Ballman K; Angulo C; Cai PY; Gaffney C; Klein E; Karnes J; Den RB; Liu Y; Davicioni E; Barbieri CE
Urol Oncol; 2020 May; 38(5):418-422. PubMed ID: 32192889
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer.
Du M; Tian Y; Tan W; Wang L; Wang L; Kilari D; Huang CC; Wang L; Kohli M
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):705-713. PubMed ID: 32203070
[TBL] [Abstract][Full Text] [Related]
13. Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters.
Salachan PV; Ulhøi BP; Borre M; Sørensen KD
Sci Rep; 2023 Dec; 13(1):22445. PubMed ID: 38105358
[TBL] [Abstract][Full Text] [Related]
14. Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data.
Williams JL; Greer PA; Squire JA
Cancer Genet; 2014; 207(10-12):474-88. PubMed ID: 25434580
[TBL] [Abstract][Full Text] [Related]
15. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
[TBL] [Abstract][Full Text] [Related]
16. The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
Bramhecha YM; Rouzbeh S; Guérard KP; Scarlata E; Brimo F; Chevalier S; Hamel L; Aprikian AG; Lapointe J
Mod Pathol; 2019 Jan; 32(1):128-138. PubMed ID: 30140035
[TBL] [Abstract][Full Text] [Related]
17. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Lehrer S; Rheinstein PH
Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
[TBL] [Abstract][Full Text] [Related]
18. Copy number alterations are associated with metastatic-lethal progression in prostate cancer.
Wang X; Grasso CS; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Troyer DA; Lance R; Feng Z; Dai JY; Stanford JL
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):494-506. PubMed ID: 32071439
[TBL] [Abstract][Full Text] [Related]
19. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
[TBL] [Abstract][Full Text] [Related]
20. PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.
Choucair K; Ejdelman J; Brimo F; Aprikian A; Chevalier S; Lapointe J
BMC Cancer; 2012 Nov; 12():543. PubMed ID: 23171135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
